Table of Contents Author Guidelines Submit a Manuscript
Case Reports in Hematology
Volume 2015, Article ID 934374, 7 pages
http://dx.doi.org/10.1155/2015/934374
Case Report

MALT Lymphoma of the Bladder: A Case Report and Review of the Literature

1Icahn School of Medicine at Mount Sinai, New York, NY 10029, USA
2Department of Radiation Oncology, Icahn School of Medicine at Mount Sinai, New York, NY 10029, USA
3Department of Pathology, Icahn School of Medicine at Mount Sinai, New York, NY 10029, USA
4Department of Medical Oncology, Icahn School of Medicine at Mount Sinai, New York, NY 10029, USA

Received 9 July 2015; Accepted 12 August 2015

Academic Editor: Marie-Christine Kyrtsonis

Copyright © 2015 Prashant Vempati et al. This is an open access article distributed under the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.

Abstract

The presentation of a MALT lymphoma in the bladder is exceedingly rare. Furthermore, the optimal treatment of primary MALT confined to the bladder remains to be defined. Here, we report a case of a 65-year-old female with primary MALT lymphoma treated with definitive radiation therapy. The patient received a total dose of 30 Gy in 20 equal daily fractions to the bladder and tolerated the treatment well. In addition, we have extensively reviewed the relevant literature to better define the optimal management of this rare disease. In conclusion, primary MALT lymphoma of the bladder represents a rare malignancy with excellent prognosis if detected at an early stage. For early stage disease, definitive radiation represents an excellent treatment modality with a minimal side-effect profile.